Skip to main content
Premium Trial:

Request an Annual Quote

Source BioScience Opens Sequencing Lab in Ireland

Premium

UK service provider Source BioScience has opened a DNA sequencing services laboratory in Dublin, Ireland, which it claims is the first commercial sequencing lab in the country.

The laboratory will be based within Trinity College Dublin. The company said it will offer DNA sequencing to customers within the university and will also provide access to "other services" through the facility, including access to sequencing and genotyping technologies that it offers through its Nottingham, UK, facility.

Source BioScience will provide technical staff to operate the Dublin facility as well as "infrastructure and technology platforms." The company also said it planned to continue to form partnerships with other academic institutions to expand its DNA sequencing facilities.

Last month, Source BioScience announced that it purchased two Illumina Genome Analyzer IIx systems and had plans to purchase the HiSeq 2000 later in the year, all for its Nottingham facility (see In Sequence 1/26/2010).

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.